Jove
Visualize
Contact Us

Related Experiment Videos

Hypertension: pathophysiologic-based management. Part II.

A Medina-Ruiz1

  • 1U.P.R. School of Medicine.

Boletin De La Asociacion Medica De Puerto Rico
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cooperative study to evaluate the efficacy and safety of enalapril in Puerto Rican patients with mild to moderate hypertension.

Drugs·1990
Same journal

Factors Associated to Invasive Fungal Infection in Hispanic Patients with Hematological Malignancies.

Boletin de la Asociacion Medica de Puerto Rico·2018
Same journal

Clinical profile, bacterial isolates, and antibiotic resistance of corneal ulcers in Puerto Rico.

Boletin de la Asociacion Medica de Puerto Rico·2017
Same journal

Secondary Resistance to dopamine agonist after thirteen months of successful treatment in a 42 years old man.

Boletin de la Asociacion Medica de Puerto Rico·2017
Same journal

Pheochromocytoma in pregnancy: A case Report.

Boletin de la Asociacion Medica de Puerto Rico·2017
Same journal

Acute Shortening and re-lengthening in the management of open tibia fractures with severe bone of 14 CMS or more and extensive soft tissue loss.

Boletin de la Asociacion Medica de Puerto Rico·2017
Same journal

Klinefelter Syndrome (49, XXXXY/48, XXXY) associated with narrow angle glaucoma: A case report.

Boletin de la Asociacion Medica de Puerto Rico·2017
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Common hypertension drugs like diuretics and beta-blockers can negatively impact metabolic health, reducing their cardiovascular benefits. Alternative antihypertensives that improve risk factors such as diabetes and dyslipidemia are recommended for better heart health.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Metabolic Health

Background:

  • Hypertension management is crucial for reducing cardiovascular disease (CVD) risk.
  • Diuretics and beta-blockers are widely used antihypertensive therapies.
  • These common treatments can lead to adverse metabolic and biochemical changes.

Purpose of the Study:

  • To evaluate the impact of diuretic and beta-blocker therapy on CVD risk factors.
  • To identify potential limitations of these therapies in managing overall cardiovascular risk.
  • To recommend alternative antihypertensive strategies.

Main Methods:

  • Review of existing literature on hypertension pharmacotherapy.
  • Analysis of metabolic and biochemical alterations associated with diuretics and beta-blockers.

Related Experiment Videos

  • Comparative assessment of different antihypertensive drug classes regarding cardiovascular risk factor modification.

    • Main Results:

    • Diuretic and beta-blocker therapies induce metabolic alterations.
    • These alterations can counteract the benefits of blood pressure reduction for coronary artery disease risk.
    • The extent of metabolic impact varies among different agents within these classes.

    Conclusions:

    • Standard hypertension therapies (diuretics, beta-blockers) may have unintended metabolic consequences.
    • These consequences can diminish the net protective effect against cardiovascular events.
    • Antihypertensive medications that positively influence diabetes and dyslipidemia should be prioritized.